89bio Inc (ETNB)
8.98
+0.01
(+0.11%)
USD |
NASDAQ |
May 20, 16:00
9.13
+0.15
(+1.67%)
After-Hours: 20:00
89bio Market Cap: 883.49M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 849.05M |
| May 16, 2024 | 882.50M |
| May 15, 2024 | 905.13M |
| May 14, 2024 | 894.31M |
| May 13, 2024 | 855.94M |
| May 10, 2024 | 856.92M |
| May 09, 2024 | 896.28M |
| May 08, 2024 | 888.41M |
| May 07, 2024 | 921.86M |
| May 06, 2024 | 943.50M |
| May 03, 2024 | 877.97M |
| May 02, 2024 | 843.69M |
| May 01, 2024 | 833.22M |
| April 30, 2024 | 810.36M |
| April 29, 2024 | 812.27M |
| April 26, 2024 | 786.56M |
| April 25, 2024 | 785.60M |
| April 24, 2024 | 817.03M |
| April 23, 2024 | 849.40M |
| April 22, 2024 | 886.54M |
| April 19, 2024 | 864.64M |
| April 18, 2024 | 845.60M |
| April 17, 2024 | 872.26M |
| April 16, 2024 | 892.26M |
| April 15, 2024 | 903.68M |
| Date | Value |
|---|---|
| April 12, 2024 | 935.11M |
| April 11, 2024 | 965.58M |
| April 10, 2024 | 1.004B |
| April 09, 2024 | 1.038B |
| April 08, 2024 | 1.027B |
| April 05, 2024 | 1.025B |
| April 04, 2024 | 1.014B |
| April 03, 2024 | 1.035B |
| April 02, 2024 | 1.007B |
| April 01, 2024 | 1.022B |
| March 28, 2024 | 1.088B |
| March 27, 2024 | 1.057B |
| March 26, 2024 | 1.047B |
| March 25, 2024 | 1.060B |
| March 22, 2024 | 1.075B |
| March 21, 2024 | 1.071B |
| March 20, 2024 | 1.058B |
| March 19, 2024 | 1.115B |
| March 18, 2024 | 1.178B |
| March 15, 2024 | 1.264B |
| March 14, 2024 | 1.179B |
| March 13, 2024 | 1.245B |
| March 12, 2024 | 1.203B |
| March 11, 2024 | 1.205B |
| March 08, 2024 | 1.209B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.53M
Minimum
May 09 2022
1.605B
Maximum
Jun 13 2023
543.82M
Average
454.37M
Median
Market Cap Benchmarks
| Akero Therapeutics Inc | 1.394B |
| Madrigal Pharmaceuticals Inc | 4.948B |
| Viking Therapeutics Inc | 7.443B |
| Galectin Therapeutics Inc | 196.39M |
| Terns Pharmaceuticals Inc | 404.56M |
Market Cap Related Metrics
| Price to Book Value | 1.731 |
| Price | 8.98 |
| Earnings Yield | -22.38% |